SEC Filing Analysis: XCF Global, Inc. (SAFX)

Executive Summary

• Trading Significance: High
• Key Takeaway: XCF Global has granted a substantial 5.25 million Restricted Stock Units (RSUs) to its departing Chief Financial Officer, Simon Oxley, as part of a transition agreement, signaling a major potential dilution event for a company of its size.
• Market Impact: The event is likely to be viewed with caution by the market due to the significant dilutive nature of the grant to a departing executive, especially as the company is simultaneously exploring new financing options.

Company Information

Field	Value
Company	XCF Global, Inc.
Ticker Symbol	SAFX
CIK	0002019793
Industry	Industrial Organic Chemicals

Insider Information

Field	Value
Name	Simon Oxley
CIK	null
Title/Position	Chief Financial Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	8-K
Transaction Date	2026-01-09
Transaction Code	A (Award)
Security Type	Restricted Stock Units (RSUs)
Shares Involved	5,246,260
Price Per Share	$0.00
Total Value	$0
Shares Owned After	null
Ownership Type	null

Financial Impact Assessment

Transaction Materiality

Note: Shares Outstanding data was not available, so a direct dilution percentage cannot be calculated. The assessment is based on the transaction's scale relative to the company's market capitalization.

Metric	Value
Transaction Value	$0 (as a grant)
% of Market Cap	0%
Shares Transacted	5,246,260
% of Shares Outstanding	Not Calculable
Materiality Assessment	Highly Significant

Impact Evaluation

• Market Cap Context: With a market capitalization of only $130 million, an equity grant of this magnitude is exceptionally large. While the reported transaction value is $0, the economic value of the shares is substantial. For context, if the stock were priced at $1.30 (implying 100 million shares outstanding), this grant would be worth over $6.8 million, or more than 5% of the company's entire market cap.
• Ownership Concentration: This transaction significantly increases the equity held by a departing executive, which will be converted into common stock, diluting other shareholders.
• Dilution Impact: The issuance of 5,246,260 new shares will materially increase the total number of shares outstanding once they vest and are issued, reducing the ownership percentage of all existing shareholders. The lack of outstanding share data prevents precise calculation, but the number of shares is clearly material.
• Transaction Significance: The significance is HIGH not because of the dollar value of the transaction itself (which is $0 for a grant), but because of the sheer number of shares being issued relative to the company's small size. This is a major compensation event and a significant future supply of stock.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: While a large, dilutive grant to a departing executive can be a negative signal, the filing frames it as part of an orderly CFO transition, with Mr. Oxley remaining as a consultant. The market may wait to see the terms of the company's new financing before reacting strongly. However, the potential for future selling pressure from these shares exists.

Volume & Sentiment

• Expected Volume Impact: Minimal immediate impact, but could lead to increased volatility or selling pressure in the future as the RSUs vest and become sellable shares.
• Sentiment Indicator: Neutral to Bearish. The market generally disfavors significant dilutive events that do not bring capital into the company, especially when paid to a departing executive.

Investment Insights

Positive Market Indicators

• The company is ensuring a smooth leadership transition by retaining the outgoing CFO in a consulting capacity.
• The company is actively pursuing growth, as evidenced by its evaluation of financing for its New Rise Reno 2 facility.

Risk Factors

• Significant Shareholder Dilution: The 5.25 million share grant represents a material dilution risk to current investors.
• Executive Payout: A large payout to a departing executive can raise concerns about corporate governance and cash/equity management.
• Capital Needs: The concurrent announcement of evaluating financing options suggests the company may require significant capital, which could lead to further dilution.

Key Takeaways

1. A major equity transfer is occurring from the company to its departing CFO.
2. The grant represents a significant potential increase in the public float and future selling pressure.
3. The company is in a critical transition phase, both in its executive leadership and its financial strategy.

Additional Context

Transaction Notes

• Timing: The event is part of a CFO transition, with Simon Oxley departing and William Dale being appointed as the new CFO, effective January 12, 2026.
• Special Circumstances: Mr. Oxley will remain with the company in a consulting role, and his consulting agreement includes provisions for additional stock-based compensation contingent on project milestones.